Tirzepatide

Category:Active Pharmaceutical Ingredients > Biochemical Ingredients > Peptides
Product Name:Tirzepatide
CAS No.:2023788-19-2
Standard:In-house Standards
Price(USD):USD1420 ~ USD1720
Company:Sichuan Jisheng Biopharmaceutical Co.,Ltd

Basic Info
  • Grade: Chemical Grade

    Factory Location: No.3 Jianye Avenue, High-Tech Zone, Leshan, Sichuan, China

    Main Sales Markets: Central/South America,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Packaging Information: 1g,10g,1kg, 5kg

  • Delivery Lead Time: 2 weeks

    Sample Provided: no

    Payment Terms: T/T

    Tirzepatide,  is a medication used for the treatment of type 2 diabetes.

    Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are hormones involved in blood sugar control.  After a person has eaten, these hormones are secreted by cells of the intestines and in turn cause the secretion of insulin. Tirzepatide is a GIP-analogue which activates both the GLP-1 and GIP receptors, leading to improved blood sugar control..

    Tirzepatide is a glucose-dependent insulin-stimulating peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist that integrates the two insulin-stimulating effects into a single molecule. Through a dual mechanism of action to activate the hormone receptors involved in blood glucose control -GIP and GLP-1 two incretin receptors.

    Tirzepatide,  is a medication used for the treatment of type 2 diabetes.

    Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are hormones involved in blood sugar control.  After a person has eaten, these hormones are secreted by cells of the intestines and in turn cause the secretion of insulin. Tirzepatide is a GIP-analogue which activates both the GLP-1 and GIP receptors, leading to improved blood sugar control..

    Tirzepatide is a glucose-dependent insulin-stimulating peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor dual agonist that integrates the two insulin-stimulating effects into a single molecule. Through a dual mechanism of action to activate the hormone receptors involved in blood glucose control -GIP and GLP-1 two incretin receptors.

Send your message to this supplier
  • From:
  • To:
    Sichuan Jisheng Biopharmaceutical Co.,Ltd
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service